miR-128-3p Inhibition Improves Muscle Mass and Function in Aged Mice
From the abstract
That the calorie restriction imposed by GLP-1 receptor agonists induces loss of muscle mass has proved a boon for research into ways to address the loss of muscle mass that occurs with age, contributing to frailty. Suddenly a relatively large amount of funding and industry attention is available for programs that might result in a drug to prevent muscle loss in GLP-1 receptor agonist patients, and most of those options can at least in principle be used to treat age-related muscle loss. Here, res
Read the full paper
This is a preview. The primary source is hosted externally — past100 links directly to the original journal paper, not a news article about it.
View original paper →Get our analysis
Each week past100 selects one paper and breaks it down: study design, effect sizes, caveats, and what a rational evidence-informed person should do with the information.
Subscribe free →